Blachman-Braun Ruben, Patel Milan, Loebach Lauren, Millan Braden, Saini Jaskirat, Gurram Sandeep, Linehan W Marston, Ball Mark W
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Urol Oncol. 2025 Aug;43(8):470.e11-470.e18. doi: 10.1016/j.urolonc.2025.03.013. Epub 2025 Apr 2.
To identify risk factors, surgical considerations, and management strategies associated with urinary leak (UL) following partial nephrectomy (PN) in a cohort that includes a significant number of patients with hereditary renal cancer syndromes, multiple tumors, and a history of prior PNs.
A retrospective chart review was conducted selecting patients who underwent PN at our institution from January 2006 to December 2023 was performed. Clinical, demographic, surgical characteristics, and management strategies were recorded and analyzed.
A total of 1,173 PNs were analyzed, of those 89(7.6%) had a UL. Patients had a median age at surgery of 50[38-59] years, 3[1-6] tumors removed per procedure with a total of 5,947 tumors were removed, 61.6% PN via the robotic approach, and the most common diagnosis was von Hippel-Lindau disease (47.4%). The frequency of UL was 5.1% for first-time PN, 10.4% for second, and 19.6% for third. An increased risk of UL was observed with higher EBL (OR = 1.016; P = 0.006) and decrease with robotic approach (OR = 0.376; P < 0.001). Overall, 44.9% of UL cases were successfully managed with conservative management (postop drain and Foley), while 98.9% were successfully managed with conservative management, ureteral stent placement, percutaneous drain, or nephrostomy tube.
UL is directly associated with the complexity of the surgery. The advantages of robotic-assisted surgery in reducing UL risk indicate potential avenues for improved outcomes. Future efforts should explore the role of intraoperative and postoperative strategies to minimize this complication. Conservative management and drain or catheter placement resolve most of the ULs.
在一个包含大量遗传性肾癌综合征患者、多发肿瘤患者以及既往接受过部分肾切除术(PN)的患者队列中,确定与PN术后尿漏(UL)相关的危险因素、手术注意事项及管理策略。
对2006年1月至2023年12月在我院接受PN的患者进行回顾性病历审查。记录并分析临床、人口统计学、手术特征及管理策略。
共分析了1173例PN,其中89例(7.6%)发生UL。患者手术时的中位年龄为50[38 - 59]岁,每次手术切除3[1 - 6]个肿瘤,共切除5947个肿瘤,61.6%的PN通过机器人手术方式进行,最常见的诊断是冯·希佩尔 - 林道病(47.4%)。首次PN的UL发生率为5.1%,第二次为10.4%,第三次为19.6%。观察到较高的术中出血量(EBL)会增加UL风险(OR = 1.016;P = 0.006),而机器人手术方式会降低UL风险(OR = 0.376;P < 0.001)。总体而言,44.9%的UL病例通过保守治疗(术后引流和留置导尿管)成功处理,而98.9%的病例通过保守治疗、输尿管支架置入、经皮引流或肾造瘘管成功处理。
UL与手术复杂性直接相关。机器人辅助手术在降低UL风险方面的优势表明了改善手术结果的潜在途径。未来的研究应探索术中及术后策略在最小化这种并发症方面的作用。保守治疗以及引流或导管置入可解决大多数UL问题。